BIOMAT Database Logo BIOMAT Database Logo

Lysis of cultured human melanoma M10 cells by polyclonal xenoantibodies to melanoma-associated antigens. 1981

R A Curry, and V Quaranta, and M A Pellegrino, and S Ferrone

Cultured human melanoma cells M10 harvested from cultures in different phases of their growth show significant changes in the expression of melanoma-associated antigens (MAA), but they do not vary in susceptibility to lysis mediated by anti-MAA xenoantisera and effected by complement or lymphoid cells. Furthermore, melanoma cells M10 showed a significant increase in susceptibility to immune lysis following treatment with puromycin at doses that do not effect the expression of MAA. The lack of correlation between MAA density and susceptibility to immune lysis supports the contention that, under the experimental conditions used, cellular properties play a major role in the outcome of immune attack.

UI MeSH Term Description Entries
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D011691 Puromycin A cinnamamido ADENOSINE found in STREPTOMYCES alboniger. It inhibits protein synthesis by binding to RNA. It is an antineoplastic and antitrypanosomal agent and is used in research as an inhibitor of protein synthesis. CL-13900,P-638,Puromycin Dihydrochloride,Puromycin Hydrochloride,Stylomycin,CL 13900,CL13900,P 638,P638
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000912 Antibodies, Neoplasm Immunoglobulins induced by antigens specific for tumors other than the normally occurring HISTOCOMPATIBILITY ANTIGENS. Neoplasm Antibodies,Tumor Antibodies,Antibodies, Tumor
D000951 Antigens, Neoplasm Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin. Neoplasm Antigens,Tumor Antigen,Tumor Antigens,Antigen, Tumor,Antigens, Tumor
D000954 Antigens, Surface Antigens on surfaces of cells, including infectious or foreign cells or viruses. They are usually protein-containing groups on cell membranes or walls and may be isolated. Cell Surface Antigens,Surface Antigens,Surface Markers, Immunological,Cell Surface Antigen,Immunologic Surface Markers,Markers, Immunological Surface,Surface Antigen,Surface Markers, Immunologic,Antigen, Cell Surface,Antigen, Surface,Antigens, Cell Surface,Immunological Surface Markers,Markers, Immunologic Surface,Surface Antigen, Cell,Surface Antigens, Cell

Related Publications

R A Curry, and V Quaranta, and M A Pellegrino, and S Ferrone
ADCC of cultured human melanoma cells: analysis with monoclonal antibodies to human melanoma-associated antigens.
October 1981, Scandinavian journal of immunology,
R A Curry, and V Quaranta, and M A Pellegrino, and S Ferrone
In vitro sensitization of human lymphoid cells to antigens on cultured melanoma cells. II. Sensitization against melanoma-associated antigens.
February 1977, Cellular immunology,
R A Curry, and V Quaranta, and M A Pellegrino, and S Ferrone
Enhanced expression of melanoma-associated antigens and beta 2-microglobulin on cultured human melanoma cells by interferon.
January 1982, Journal of the National Cancer Institute,
R A Curry, and V Quaranta, and M A Pellegrino, and S Ferrone
Membrane associated antigens of human malignant melanoma. III. Specificity of human sera reacting with cultured melanoma cells.
February 1977, International journal of cancer,
R A Curry, and V Quaranta, and M A Pellegrino, and S Ferrone
Relationship of melanoma-associated antigens to histocompatibility antigen and beta-2 microglobulin in material spontaneously shed by cultured human melanoma cells.
March 1983, Transplantation,
R A Curry, and V Quaranta, and M A Pellegrino, and S Ferrone
Spectrum of melanoma antigens on cultured human malignant melanoma cells as detected by monkey antibodies.
January 1979, Cancer research,
R A Curry, and V Quaranta, and M A Pellegrino, and S Ferrone
Differential effect of interferon on the expression of tumor-associated antigens and histocompatibility antigens on human melanoma cells: relationship to susceptibility to immune lysis mediated by monoclonal antibodies.
August 1981, Journal of immunology (Baltimore, Md. : 1950),
R A Curry, and V Quaranta, and M A Pellegrino, and S Ferrone
Antigenic profile of human melanoma cells. Analysis with monoclonal antibodies to histocompatibility antigens and to melanoma-associated antigens.
August 1983, Journal of cutaneous pathology,
R A Curry, and V Quaranta, and M A Pellegrino, and S Ferrone
Human melanoma-associated antigens.
January 1989, Immunology series,
R A Curry, and V Quaranta, and M A Pellegrino, and S Ferrone
Clot lysis mediated by cultured human microvascular endothelial cells.
December 1988, Thrombosis and haemostasis,
Copied contents to your clipboard!